Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Eligo Bioscience
Precision medicines for the microbiome
TL;DR
Headquarters: Paris, France
Platform: GEM / Eligobiotics (in vivo bacterial gene editing)
Focus: Precision microbiome genetic medicines (edit or kill target bacteria)
Recent funding: $30M Series B (Dec 2023); total funding reported ~$74.7M
Founding leadership: Xavier Duportet (Co-founder & CEO) with scientific cofounders David Bikard, Luciano Marraffini, Timothy Lu
Company Overview
Problem Domain
Microbiome-targeted therapeutics; precision genetic medicines against specific bacterial targets
Industry
Biotechnology
Funding Track Record
$30,000,000
Participation from Bpifrance, Khosla Ventures and Seventure Partners
$20,000,000
Existing investor Seventure Partners participated; included a government grant component in coverage
$5,000,000
France 2030 / Bpifrance non-dilutive funding
Investor Signal
“Includes strategic life-science investors (Sanofi Ventures) and prominent VC/backers (Khosla Ventures, Seventure Partners) and public funding from Bpifrance”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week